# Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers

> **NCT03936907** · PHASE1 · COMPLETED · sponsor: **One World Cannabis Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** OWCP Orally Disintegrating Tablet
- **DRUG:** Sativex

## Key facts

- **NCT ID:** NCT03936907
- **Lead sponsor:** One World Cannabis Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-07-18
- **Final completion:** 2019-07-18
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936907, "Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03936907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*